Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-25-020478
Filing Date
2025-04-29
Accepted
2025-04-29 08:04:19
Documents
22
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A zlab-20250429.htm   iXBRL DEF 14A 1171506
3 zlab-20250429_g1.jpg GRAPHIC 14140
4 zlab-20250429_g2.jpg GRAPHIC 4107
5 zlab-20250429_g3.jpg GRAPHIC 3172
6 zlab-20250429_g4.jpg GRAPHIC 76303
7 zlab-20250429_g5.jpg GRAPHIC 371993
8 zlab-20250429_g6.jpg GRAPHIC 252661
9 zlab-20250429_g7.jpg GRAPHIC 242468
10 zlab-20250429_g8.jpg GRAPHIC 459270
11 zlab-20250429_g9.jpg GRAPHIC 390288
  Complete submission text file 0001628280-25-020478.txt   6311574

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zlab-20250429.xsd EX-101.SCH 912
24 EXTRACTED XBRL INSTANCE DOCUMENT zlab-20250429_htm.xml XML 235541
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38205 | Film No.: 25882770
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)